Make-A-Wish Receives Donation from Prolacta Bioscience – CSR

It feels good to affiliate with clients that are socially responsible. This includes PilmerPR clients Milk for Wishes Milk Bank & Prolacta Bioscience.

Prolacta Bioscience, the first and only company to offer human milk fortifier (HMF) made from 100% human breast milk for critically ill, premature infants, announced today an initial donation of $7500 to the Make-A-Wish Foundation®. Prolacta’s donation is part of an annual sponsorship of the Make-A-Wish Foundation. The sponsorship guarantees a minimum annual donation of $30,000 from Prolacta.

The financial donations from Prolacta are being made as a result of breast milk donations made through the Milk for Wishes Milk Bank (MFW). Under the sponsorship, Prolacta donates one dollar to the Make-A-Wish Foundation for every ounce of qualified breast milk collected through MFW. MFW was established to provide human milk-based products to premature infants in the neonatal intensive care unit (NICU), as well as to help the Make-A-Wish Foundation grant wishes of children with life-threatening medical conditions.

Breast milk that is donated through MFW is used by Prolacta to make human milk-based nutritional products to benefit critically ill, premature infants who are hospitalized in NICUs throughout the U.S.  Premature infants have increased nutritional needs above what can be provided by their mother’s milk or donor milk alone, so the breast milk that is fed to them needs to be fortified with added nutrients. Prolacta’s Prolact+ H2MF® is the first and only commercially available HMF made from 100% human milk for premature infants who are born weighing between 500 and 1250g. Prior to Prolact+ H2MF, cow milk-based HMF was the only option neonatologists had for premature infant feeding fortification in the NICU.

Several studies point to the benefits of using human milk in premature infant nutrition over cow milk-based nutrition. One such study was published in the Journal of Pediatrics in 2010. It concluded that when Prolact+ H2MF was added to human milk, the odds of developing necrotizing enterocolitis (NEC) was reduced by 77% in premature infants weighing between 500 and 1250g at birth, when compared to infants receiving human milk fortified with cow milk-based HMF or, when supply or mother’s own milk was insufficient, preterm infant formula. NEC is a dangerous intestinal condition that often affects extremely preterm infants, in which the intestinal tissue disintegrates1 (http://www.jpeds.com/article/S0022-3476(09)01085-3/abstract).

Mothers who wish to learn more information, or to find out if they qualify to donate milk may visit www.milkforwishes.com.

About the Author:

As founder of PilmerPR, John Pilmer, APR serves as a PR and marketing communications advisor for both emerging and established companies. He offers customers more than 20 years of results-driven business PR and marketing experience. John and the firm have provided PR consultation and campaigns for clients such as Mozy, Novell, AdvancedMD, Certiport, NextPage, ElectraTherm, Altiris, Avamar, EmergeCore Networks, FSLogic, INVISUS, 10x Marketing, MWI, Project Insight, REIC, Seastone, US Synthetic and Funding Universe (now Lendio), among others.
  Related Posts

Add a Comment